Seres Therapeutics, Inc. MCRB
$4.87
+1.04%
at last close
Market Cap$48.41 million
P/E Ratio—
Div Yield—
Volume62.3K
52-Week Range
$4.59$29.98
Key Stats
- Today's Range
- $4.82 – $5.19
- 50-Day Range
- $4.59 – $8.25
- 52-Week Range
- $4.59 – $29.98
- Volume
- 62K shs
- Average Volume
- 103K shs
- Market Cap
- $48.41 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.40
- Price / Sales
- 25.71
Short Interest
- Short Interest
- 49.60%
- Days to Cover
- 28.86
Financials (TTM)
- Revenue
- $1.88 million
- Net Income
- $-22,463,000
- Net Margin
- -1192.94%
- Return on Equity
- -65.05%
- Debt-to-Equity
- —
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Related Stocks
Compare head-to-head: MCRB vs LLY·MCRB vs JNJ·MCRB vs ABBV·MCRB vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.